Maximum Strength Mucinex Fast-max Cold And Flu Capsule, Liquid Filled
Pricing Report NDC 63824-518-16

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The latest wholesale acquisition cost for Maximum Strength Mucinex Fast-max Cold And Flu (NDC 63824-518-16) is $0.73688 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 23, 2022.

As a a human over the counter drug provided by Reckitt Benckiser Llc, this medication is distributed in a 2 BLISTER PACK in 1 CARTON / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.73688
Per EA

Effective Date
Mar 23, 2022
Billable Units
2 EA
Estimated Package Price
$1.47
Data Status
As of Jun 29, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
2 BLISTER PACK in 1 CARTON / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2019, the NADAC wholesale price for (NDC ) has moved within a range of $0.68675 to $0.76730 per EA. Over this 2 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.6868 - $0.7673
Market Volatility
11.73% Variance
Latest Trend
2.02%
Date Unit Price Unit Source Method Rate
Mar 23, 2022 $0.73688 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 23, 2022 $0.73688 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Mar 23, 2022 $0.73688 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Mar 23, 2022 $0.73688 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 23, 2022 $0.72226 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 23, 2022 $0.72226 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 22, 2021 $0.76632 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 22, 2021 $0.76632 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 22, 2021 $0.76632 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 22, 2021 $0.76632 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Oct 20, 2021 $0.74469 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 20, 2021 $0.74469 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Oct 20, 2021 $0.74469 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 20, 2021 $0.74469 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Sep 29, 2021 $0.76730 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 22, 2021 $0.76730 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 19, 2021 $0.73399 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 19, 2021 $0.73399 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
May 19, 2021 $0.73399 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Dec 23, 2020 $0.71323 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 23, 2020 $0.71323 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Dec 23, 2020 $0.71323 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jun 17, 2020 $0.71063 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 17, 2020 $0.71063 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jun 17, 2020 $0.71063 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Apr 22, 2020 $0.68837 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 22, 2020 $0.68837 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Oct 23, 2019 $0.68675 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026